Navigation Links
Wellcome Trust Sanger Institute to use NEBNext(TM) DNA Sample Preparation Reagents from New England Biolabs for Next Generation Sequencing
Date:2/4/2010

IPSWICH, Mass., Feb. 4 /PRNewswire/ -- As an important supplier to the Wellcome Trust Sanger Institute, New England Biolabs is pleased to announce that the Sanger Institute will use New England Biolabs as one of its suppliers for next-generation sequencing library construction reagents.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090921/NE79207LOGO-b )

"We are extremely pleased that the Wellcome Trust Sanger Institute, as a world leading genome center, has determined that our reagents meet their high standards," stated Peter Nathan, Director of Global Business Development at New England Biolabs.

NEBNext™ DNA Sample Prep Reagent Sets contain enzymes and buffers that are ideally suited for sample preparation for next generation sequencing, as well as the preparation of expression libraries. Reagents are available for each step of library construction workflow and are compatible with the Illumina® GAII, Roche/454 GS FLX Titanium™ and the Life SOLiD™ 3 platforms. These sets are highly cost effective and each of the components must pass rigorous quality control and functional validation.

About NEB

Established in mid 1970s, New England Biolabs, Inc. leads the industry in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, cellular analysis and RNA analysis. Additionally, NEB is focusing on strengthening alliances that enable new technologies to reach key market sectors. New England Biolabs is a privately held company headquartered in Ipswich, MA and has extensive worldwide distribution through a network of exclusive distributors, agents and five subsidiaries located in Canada, China, Germany, Japan and the UK. For more information about New England Biolabs visit www.neb.com.

Illumina is a registered trademark of Illumina, Inc.

GS FLX Titanium is a trademark of Roche.

SOLiD is a trademark of Life Technologies.

SOURCE New England Biolabs, Inc.

RELATED LINKS
http://www.neb.com

'/>"/>

SOURCE New England Biolabs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
2. KGI Elects Three New Members to Board of Trustees
3. BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends
4. Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment from M.J. Murdock Charitable Trust
5. Siemens Receives EU Antitrust Clearance for Acquisition of Dade Behring
6. BioMed Realty Trust Appoints Executive Officer of the Irvine Company to Its Board
7. HealthTrust Expands Contract With Instrumentation Laboratory for Critical Care Portfolio to Include Consorta
8. Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group
9. BioMed Realty Trust To Report 2007 Fourth Quarter and Year-End Results
10. BioMed Realty Trust Announces Tax Treatment of 2007 Distributions
11. Purchase Agreement for Antibody Manufacturing Facility Receives Antitrust Clearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... Seattle, WA (PRWEB) , ... June 23, 2016 ... ... technology, announces the release of its second eBook, “Clinical Trials Patient Recruitment and ... patient recruitment and retention in this eBook by providing practical tips, tools, and ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
Breaking Biology News(10 mins):